BioCryst Pharmaceuticals Inc (BCRX)

[Deano361]

Should they have not gave us the 7 day report on this as they head into the 56 day phase for others?

"The first part of the study will involve three groups of eight patients randomized to receive intravenous galidesivir or a placebo every 12 hours for seven days, BioCryst said. "